Evaluating the trabecular micro-bypass stent combined with phacoemulsification compared to phacoemulsification alone
M El Wardani1, C Bergin1, F Achache1
1Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, Foundation Asile des Aveugles, Lausanne, Switzerland.
Klinische Monatsblatter Fur Augenheilkunde
|April 23, 2015
Summary
iStent implantation with phacoemulsification significantly reduced glaucoma medications compared to phacoemulsification alone. This combination therapy offers potential benefits for early to moderate glaucoma patients.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Innovation
Background:
- Glaucoma management often involves intraocular pressure (IOP) reduction and medication adherence.
- Phacoemulsification is a common cataract surgery.
- Trabecular micro-bypass stents offer a minimally invasive glaucoma surgical option.
Purpose of the Study:
- To evaluate the efficacy of iStent implantation combined with phacoemulsification.
- To compare IOP and glaucoma medication reduction with phacoemulsification alone.
Main Methods:
- Retrospective comparative study of 131 eyes with ocular hypertension/glaucoma.
- Groups: phacoemulsification alone (n=78), one iStent + phacoemulsification (n=31), two iStents + phacoemulsification (n=22).
- Postoperative assessment of IOP, visual acuity, and medication use up to 6 months.
Main Results:
- All groups showed IOP reduction; group III (two iStents) achieved statistically significant reduction (p=0.05).
- Glaucoma medication use decreased significantly in both iStent groups (II: 27%, p=0.04; III: 45%, p<0.01).
- Phacoemulsification alone showed minimal medication reduction (8%, p=0.12).
Conclusions:
- iStent implantation combined with phacoemulsification provides significant medication reduction in glaucoma patients.
- This approach may enhance patient compliance and quality of life.
- The combination therapy is a viable option for early to moderate glaucoma.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K